Atlantic Union Bankshares Corp trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,110 shares of the healthcare conglomerate’s stock after selling 3,286 shares during the quarter. UnitedHealth Group comprises 1.0% of Atlantic Union Bankshares Corp’s holdings, making the stock its 18th largest position. Atlantic Union Bankshares Corp’s holdings in UnitedHealth Group were worth $10,146,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. BlackRock Inc. increased its stake in shares of UnitedHealth Group by 0.7% in the first quarter. BlackRock Inc. now owns 74,928,539 shares of the healthcare conglomerate’s stock worth $35,410,478,000 after acquiring an additional 509,633 shares during the period. Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 0.6% in the first quarter. Wellington Management Group LLP now owns 24,079,140 shares of the healthcare conglomerate’s stock valued at $11,379,561,000 after acquiring an additional 140,312 shares during the period. Geode Capital Management LLC grew its position in UnitedHealth Group by 1.4% during the first quarter. Geode Capital Management LLC now owns 17,101,395 shares of the healthcare conglomerate’s stock valued at $8,063,262,000 after buying an additional 242,959 shares during the period. Morgan Stanley boosted its stake in shares of UnitedHealth Group by 13.8% during the 4th quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after acquiring an additional 1,893,192 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC grew its holdings in UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Hedge funds and other institutional investors own 85.69% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of UNH stock opened at $486.06 on Tuesday. The firm has a market cap of $450.24 billion, a P/E ratio of 21.75, a P/E/G ratio of 1.43 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $558.10. The firm’s 50 day moving average price is $492.05 and its 200-day moving average price is $486.73.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be paid a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.65%.
Insider Activity at UnitedHealth Group
In related news, CEO Andrew Witty sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the completion of the sale, the chief executive officer now owns 78,573 shares in the company, valued at $39,772,866.87. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.35% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on UNH shares. Morgan Stanley restated an “overweight” rating and set a $587.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 14th. Truist Financial lowered their price objective on UnitedHealth Group from $610.00 to $580.00 in a report on Wednesday, June 14th. Mizuho lowered their price target on UnitedHealth Group from $600.00 to $549.00 in a research note on Tuesday, July 11th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Thursday, September 14th. Finally, HSBC assumed coverage on shares of UnitedHealth Group in a research note on Wednesday, September 6th. They issued a “hold” rating and a $540.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $575.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- What is the Hang Seng index?
- 2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
- The 3 Best Blue-Chip Stocks to Buy Now
- 5 Reasons Mullen Automotive is About to Turn a Corner
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Qualcomm and Apple Forge Ahead with New Modem Partnership
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.